vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $487.7M, roughly 1.3× CLOVER HEALTH INVESTMENTS, CORP.). Hims & Hers Health, Inc. runs the higher net margin — 3.3% vs -10.1%, a 13.4% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 28.4%). Hims & Hers Health, Inc. produced more free cash flow last quarter ($-2.5M vs $-69.0M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs 18.6%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
CLOV vs HIMS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $487.7M | $617.8M |
| Net Profit | $-49.3M | $20.6M |
| Gross Margin | — | 71.9% |
| Operating Margin | -10.1% | 1.5% |
| Net Margin | -10.1% | 3.3% |
| Revenue YoY | 44.7% | 28.4% |
| Net Profit YoY | -123.2% | -20.8% |
| EPS (diluted) | — | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $487.7M | $617.8M | ||
| Q3 25 | $496.6M | $599.0M | ||
| Q2 25 | $477.6M | $544.8M | ||
| Q1 25 | $462.3M | $586.0M | ||
| Q4 24 | $337.0M | $481.1M | ||
| Q3 24 | $331.0M | $401.6M | ||
| Q2 24 | $356.3M | $315.6M | ||
| Q1 24 | $346.9M | $278.2M |
| Q4 25 | $-49.3M | $20.6M | ||
| Q3 25 | $-24.4M | $15.8M | ||
| Q2 25 | $-10.6M | $42.5M | ||
| Q1 25 | $-1.3M | $49.5M | ||
| Q4 24 | $-22.1M | $26.0M | ||
| Q3 24 | $-9.2M | $75.6M | ||
| Q2 24 | $7.4M | $13.3M | ||
| Q1 24 | $-19.2M | $11.1M |
| Q4 25 | — | 71.9% | ||
| Q3 25 | — | 73.8% | ||
| Q2 25 | — | 76.4% | ||
| Q1 25 | — | 73.5% | ||
| Q4 24 | — | 76.8% | ||
| Q3 24 | 24.5% | 79.2% | ||
| Q2 24 | 30.3% | 81.3% | ||
| Q1 24 | 23.6% | 82.4% |
| Q4 25 | -10.1% | 1.5% | ||
| Q3 25 | -4.9% | 2.0% | ||
| Q2 25 | -2.2% | 4.9% | ||
| Q1 25 | -0.3% | 9.9% | ||
| Q4 24 | -6.4% | 3.9% | ||
| Q3 24 | -2.7% | 5.6% | ||
| Q2 24 | 2.0% | 3.5% | ||
| Q1 24 | -6.5% | 3.6% |
| Q4 25 | -10.1% | 3.3% | ||
| Q3 25 | -4.9% | 2.6% | ||
| Q2 25 | -2.2% | 7.8% | ||
| Q1 25 | -0.3% | 8.4% | ||
| Q4 24 | -6.6% | 5.4% | ||
| Q3 24 | -2.8% | 18.8% | ||
| Q2 24 | 2.1% | 4.2% | ||
| Q1 24 | -5.5% | 4.0% |
| Q4 25 | — | $0.08 | ||
| Q3 25 | — | $0.06 | ||
| Q2 25 | — | $0.17 | ||
| Q1 25 | — | $0.20 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.32 | ||
| Q2 24 | — | $0.06 | ||
| Q1 24 | — | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.3M | $228.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $308.7M | $540.9M |
| Total Assets | $541.0M | $2.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.3M | $228.6M | ||
| Q3 25 | — | $345.8M | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $273.7M | ||
| Q4 24 | $194.5M | $220.6M | ||
| Q3 24 | $288.0M | $165.5M | ||
| Q2 24 | $254.8M | $129.3M | ||
| Q1 24 | $208.3M | $105.2M |
| Q4 25 | $308.7M | $540.9M | ||
| Q3 25 | $340.9M | $581.0M | ||
| Q2 25 | $344.2M | $562.7M | ||
| Q1 25 | $336.1M | $549.3M | ||
| Q4 24 | $341.1M | $476.7M | ||
| Q3 24 | $342.2M | $440.1M | ||
| Q2 24 | $324.9M | $362.0M | ||
| Q1 24 | $292.5M | $344.5M |
| Q4 25 | $541.0M | $2.2B | ||
| Q3 25 | $559.7M | $2.2B | ||
| Q2 25 | $575.0M | $1.9B | ||
| Q1 25 | $583.7M | $891.7M | ||
| Q4 24 | $580.7M | $707.5M | ||
| Q3 24 | $653.0M | $602.3M | ||
| Q2 24 | $674.2M | $480.5M | ||
| Q1 24 | $671.8M | $448.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-66.9M | $61.3M |
| Free Cash FlowOCF − Capex | $-69.0M | $-2.5M |
| FCF MarginFCF / Revenue | -14.1% | -0.4% |
| Capex IntensityCapex / Revenue | 0.4% | 10.3% |
| Cash ConversionOCF / Net Profit | — | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | $-69.2M | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-66.9M | $61.3M | ||
| Q3 25 | $12.1M | $148.7M | ||
| Q2 25 | $5.4M | $-19.1M | ||
| Q1 25 | $-16.3M | $109.1M | ||
| Q4 24 | $34.8M | $86.4M | ||
| Q3 24 | $50.0M | $85.3M | ||
| Q2 24 | $44.8M | $53.6M | ||
| Q1 24 | $25.9M | $25.8M |
| Q4 25 | $-69.0M | $-2.5M | ||
| Q3 25 | $11.4M | $79.3M | ||
| Q2 25 | $4.8M | $-69.5M | ||
| Q1 25 | $-16.5M | $50.1M | ||
| Q4 24 | $33.3M | $59.5M | ||
| Q3 24 | $49.6M | $79.4M | ||
| Q2 24 | $44.4M | $47.6M | ||
| Q1 24 | $25.5M | $11.8M |
| Q4 25 | -14.1% | -0.4% | ||
| Q3 25 | 2.3% | 13.2% | ||
| Q2 25 | 1.0% | -12.8% | ||
| Q1 25 | -3.6% | 8.5% | ||
| Q4 24 | 9.9% | 12.4% | ||
| Q3 24 | 15.0% | 19.8% | ||
| Q2 24 | 12.5% | 15.1% | ||
| Q1 24 | 7.3% | 4.3% |
| Q4 25 | 0.4% | 10.3% | ||
| Q3 25 | 0.1% | 11.6% | ||
| Q2 25 | 0.1% | 9.3% | ||
| Q1 25 | 0.0% | 10.1% | ||
| Q4 24 | 0.5% | 5.6% | ||
| Q3 24 | 0.1% | 1.5% | ||
| Q2 24 | 0.1% | 1.9% | ||
| Q1 24 | 0.1% | 5.0% |
| Q4 25 | — | 2.98× | ||
| Q3 25 | — | 9.43× | ||
| Q2 25 | — | -0.45× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | — | 3.32× | ||
| Q3 24 | — | 1.13× | ||
| Q2 24 | 6.04× | 4.03× | ||
| Q1 24 | — | 2.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
